drugset / Trial / NCT00358579

Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest

NCT00358579

RandomizedParallel-groupDouble-blindTreatment

Summary

The effectiveness of medications in cardiac arrest has been greatly debated and questioned. Historically intravenous adrenaline has been the drug of choice since 1906. There have been few formal evaluations to determine the value of adrenaline for cardiac arrest, and clinical trials have not been able to show any benefit with intravenous adrenaline (compared to placebo or no treatment) in the field. Thus the purpose of this study is to compare vasopressin and adrenaline in the treatment of cardiac arrest to answer the question whether there is an improvement in survival between vasopressin and adrenaline.

Timeline

Start
2006-03
Primary completion
2009-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified 1 mg Intravenous
Comparator Vasopressin Peptide 40 iu Intravenous

Indications